Header Image

1st Annual BioSpot Conference

Date: February 24th, 2016carolyn_vizual_4
Venue: DOX Gallery, Prague
Download Press Release here (Czech language), here (English Language)

The first year the Conference attracted 40 participants from academia and representatives of venture capital companies. BioSpot Database collected during the first year of its existence 30 technologies and thanks to 1st Annual Conference 1 technology has been licensed.

CONFERENCE PROGRAMME:

10:00 – 10:30   Welcome speeches, Introduction to Biospot

10:30 – 12:00   Oral presentations – Section I (chair: Michal Votruba, MD., RSJ PE)
10:30 – 11:00    iBodies – modular synthetic antibodies (Tomáš Knedlík, PhD., Institute of Organic Chemistry and Biochemistry AS CR, Prague)
11:00 – 11:30     Innate immunity based cancer immunotherapy (Jan Ženka, PhD., Faculty of Science, University of South Bohemia, České Budějovice)
11:30 – 12:00    Method of HER2 gene copy number quantification in samples with indeterminate ISH (V. Koudeláková, PhD., Institute of Molecular and Translational Medicine, Palacky University, Olomouc) – licensed at BioSpot

12:00 – 13:00    Lunch & poster presentations

13:00 – 14:30   Oral presentations – Section II (chair: Jaromír Zahrádka, PhD., IOCB TTO, Prague)
13:00 – 13:30   Magnetic SERS as a new diagnostic tool (Václav Ranc, PhD., Regional Centre of Advanced Technologies and Materials, Palacky university, Olomouc)
13:30 – 14:00   Bifunctional ligands for efficient 64Cu labelling (Petr Hermann, Prof., Faculty of Science, Charles University, Prague)
14:00 – 14:30    Ultra-fast radiotherapy device (Gabriele Maria Grittani, PhD., ELI – Beamlines, IP AS CR, Prague)

14:30 – 15:00   Coffee break

15:00 – 15:45    Investor’s insights: Case studies and examples of good practice (Matěj Kumštýř, RSJ PE, Lukáš Havel, BNT Attorneys-at-Law)

15:45 – 16:00   Conclusion remarks

PRESENTED TECHNOLOGIES:

ORAL PRESENTATIONS:

Welcome speach (Martin Fusek, Prof., IOCB TTO, Prague)
Introduction to BioSpot (Marián Hajdúch, MD., PhD., Institute of Molecular and Translational Medicine, Palacky University, Olomouc)
iBodies – modular synthetic antibodies (Tomáš Knedlík, PhD.,Institute of Organic Chemistry and Biochemistry AS CR, Prague)
Innate immunity based cancer immunotherapy (Jan Ženka, CSc., Faculty of Science, University of South Bohemia, České Budějovice)
Method of HER2 gene copy number quantification in samples with indeterminate ISH (V. Koudeláková, PhD.,Institute of Molecular and Translational Medicine, Palacky University, Olomouc) – licensed at BioSpot
Magnetic SERS as a new diagnostic tool (Václav Ranc, PhD., Regional Centre of Advanced Technologies and Materials, Palacky University, Olomouc)
Bifunctional ligands for efficient 64Cu labelling (Petr Hermann, Prof., Faculty of Science, Charles University, Prague)
Ultra-fast radiotherapy device (Gabriele Maria Grittani, PhD., ELI – Beamlines, IP AS CR, Prague)
Investor’s insights: Case studies and examples of good practice (Matěj Kumštýř, RSJ PE, Lukáš Havel BNT Attorneys- at-Law)

POSTER PRESENTATIONS:

Lectin-based process for chicken antibody purification (Petr Hodek,prof., Faculty of Science, Charles University, Prague)
Culture chamber for biocompatibility testing of opaque implant material and live cells (Vítězslav Březina, PhD., Masaryk University, Brno)
An in-vitro sensor for early-stage neoplastic disease (Lakshman Varanasi, PhD., Institute of Molecular and Translational Medicine, Palacky University, Olomouc)
ABAD inhibitors – novel therapeutic strategy to treat alzheimer’s disease (Lucie Bartošová, University Hospital, Hradec Králové)
Novel NMDA receptor antagonists, potent CNS therapeutics (Jan Šotola, Dr.,Institute of Organic Chemistry and Biochemystry AS CR, Prague)
Anti-Inflammatories (Jan  Šotola, Dr., Institute of Organic Chemistry and Biochemystry AS CR, Prague)
Software for identification of mutant proteins, splicing variants and SNPs in MS/MS data (Miroslav Hruška, Institute of Molecular and Translational Medicine, Palacky University, Olomouc)
Diagnostic kit for HPV detection (Hana Jaworek Ondryášová, Institute of Molecular and Translational Medicine, Palacky University, Olomouc)
Method of predicting the tumor response to DNA methylation inhibitors and alternative therapeutic regimens for overcoming resistance (Khushboo Agrawal, MSc., Institute of Molecular and Translational Medicine, Palacky University, Olomouc)
Method for obtaining follicular cells and a device for carrying out this method (Martin Mistrík, PhD., Institute of Molecular and Translational Medicine, Palacky University, Olomouc)